Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats

Journal of Neurochemistry

Volumn 68, Issue 3, 1997, Pages 1326-1329

  Gobert, A ^a   Rivet, J M ^a   Cistarelli, L ^a   Millan, M J ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Buspirone; Cortex; Duloxetine; Fluoxetine; Microdialysis; Monoamines

Indexed keywords

BUSPIRONE; DOPAMINE; DULOXETINE; FLUOXETINE; NORADRENALIN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIALYSATE; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG ACTIVITY; DRUG INHIBITION; DRUG POTENTIATION; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0031017894     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68031326.x     Document Type: Article

References (23)

1. 1A antagonists. Trends Neurosci. 19, 378-383.
2. Blier P. and Bergeron R. (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharmacol. 15, 217-222.
3. 1A receptors negatively coupled with adenylate cyclase in hippocampal neurons. Naunyn Schmiedebergs Arch. Pharmacol. 335, 588-592.
4. Cappiello A., McDougle C. J., Malison R. T., Heninger G. R., and Price L. H. (1995) Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study. Biol. Psychiatry 38, 765-767.
5. 2-adrenoceptor antagonism and depression. Drug News Perspect. 4, 197-203.
6. 2-receptor blockade. J. Neural Transm. 76, 91-98.
7. Engleman E. A., Perry K. W., Mayle D. A., and Wong D. T. (1995) Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor. Neuropsychopharmacology 12, 287-295.
8. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115, 1064-1070.
9. 3 (auto) receptors inhibit dopamine release in the frontal cortex of freely-moving rats in vivo. J. Neurochem. 66, 2209-2212.
10. 1B receptors with WAY 100,635 and GR 127,935. J. Neurochem. 68, 1159-1163.
11. Hjorth S. (1996) (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. Eur. J. Pharmacol. 303, 183-186.
12. Joffe R. T. and Schuller D. R. (1993) An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J. Clin. Psychiatry 54, 269-271.
13. Kihara T. and Ikeda M. (1995) Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex. J. Pharmacol. Exp. Ther. 272, 177-183.
14. 1A autoreceptors enhances dopamine (DA) and noradrenaline (NAD) release in rat frontal cortex: influence of S 15535, WAY 100,635 and 8-OH-DPAT. Eur. Neuropsychopharmacol. 6 (Suppl.), S4.121-S4.122.
15. Maes M. and Meltzer H. Y. (1995) The serotonin hypothesis of major depression, in Psychopharmacology: The Fourth Generation in Progress (Bloom F. E. and Kupfer D. J., eds), pp. 933-944. Raven Press, New York.
16. Murphy D. L., Mitchell P. B., and Potter W. Z. (1995) Novel pharmacological approaches to the treatment of depression, in Psychopharmacology: The Fourth Generation in Progress (Bloom F. E. and Kupfer D. J., eds), pp. 1143-1154. Raven Press, New York.
17. Pessia M., Jiang Z. G., North R. A., and Johnson S. W. (1994) Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res. 654, 324-330.
18. Schatzberg A. F. and Schildkraut J. J. (1995) Recent studies on norepinephrine systems in mood disorders, in Psychopharmacology: The Fourth Generation in Progress (Bloom F. E. and Kupfer D. J., eds), pp. 911-920. Raven Press, New York.
19. Tanda G., Carboni E., Frau R., and Di Chiara G. (1994) Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berlin) 115, 285-288.
20. 3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex. Psychopharmacology (Berlin) 119, 15-19.
21. 1A receptors in the rat prefrontal cortex. Eur. J. Pharmacol. 305, 73-78.
22. Wolfersdorf M., Barg T., Konig F., Leibfarth M., and Grunewald I. (1995) Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use. Pharmacopsychiatry 28, 56-60.
23. Zacharko R. M. and Anisman H. (1991) Stressor-induced anhedonia in the mesocorticolimbic system. Neurosci. Biobehav. Rev. 15, 391-405.